Finance

Lists
688136:SHA
Kexing Biopharm Co Ltd
20,17 CN¥
-1,13%
(-0,23) 1D
16 հոկ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688136...
Open
20,70 CN¥
High
21,75 CN¥
Low
19,90 CN¥
Mkt. cap
4,12 մլրդ
Avg. vol.
7,50 մլն
Volume
8,28 մլն
Dividend
1,24%
Quarterly dividend
0,06 CN¥
Ex-dividend date
15 հնս, 2026 թ.
P/E ratio
18,80
52-wk high
41,50 CN¥
52-wk low
17,00 CN¥
EPS
1,07 CN¥
No. of employees
1 հզր
Open
20,70 CN¥
High
21,75 CN¥
Low
19,90 CN¥
Mkt. cap
4,12 մլրդ
Avg. vol.
7,50 մլն
Volume
8,28 մլն
Dividend
1,24%
Quarterly dividend
0,06 CN¥
Ex-dividend date
15 հնս, 2026 թ.
P/E ratio
18,80
52-wk high
41,50 CN¥
52-wk low
17,00 CN¥
EPS
1,07 CN¥
No. of employees
1 հզր
News stories
From web sources and news partners
About Kexing Biopharm Co Ltd
CEO-
Employees1,11 հզր
Founded22 օգս, 1997 թ.
Headquarters-
Sector-
Websitekexing.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
447,17 մլն
386,39 մլն
280,53 մլն
326,60 մլն
Cost of goods sold
162,17 մլն
145,91 մլն
116,00 մլն
164,22 մլն
Cost of revenue
162,17 մլն
145,91 մլն
116,00 մլն
164,22 մլն
Research and development expenses
50,96 մլն
66,93 մլն
34,07 մլն
67,52 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187,99 մլն
181,65 մլն
130,45 մլն
159,64 մլն
Operating expense
247,60 մլն
247,70 մլն
168,33 մլն
228,90 մլն
Total operating expenses
409,77 մլն
393,61 մլն
284,32 մլն
393,11 մլն
Operating income
37,41 մլն
-7,22 մլն
-3,80 մլն
-66,51 մլն
Other non operating income
4,38 մլն
-3,77 մլն
-7,85 մլն
7,38 մլն
EBT including unusual items
31,21 մլն
50,36 մլն
-25,83 մլն
172,90 մլն
EBT excluding unusual items
28,21 մլն
-15,50 մլն
-19,05 մլն
-80,87 մլն
Income tax expense
1,07 մլն
6,72 մլն
-7,28 մլն
21,86 մլն
Effective tax rate
3,43%
13,34%
28,18%
12,65%
Other operating expenses
3,60 մլն
3,58 մլն
1,19 մլն
3,46 մլն
Net income
30,92 մլն
44,30 մլն
-17,94 մլն
151,88 մլն
Net profit margin
6,91%
11,47%
-6,39%
46,50%
Earnings per share
-
-
-
-
Interest and investment income
4,79 մլն
3,35 մլն
3,04 մլն
956,57 հզր
Interest expense
-10,40 մլն
-11,62 մլն
-10,44 մլն
-10,68 մլն
Net interest expenses
-5,61 մլն
-8,27 մլն
-7,40 մլն
-9,73 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
58,93 մլն
16,78 մլն
20,20 մլն
-41,95 մլն
Gain or loss from assets sale
-114,72 հզր
-954,82 հզր
-
-22,73 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps